In animals and in man, diverse immunologic functions are mediated by specialized T-cell (thymus-derived lymphocyte) subsets that are distinguishable from one another on the basis of differences in cell surface determinants. Unfortunately, in humans, subset-specific antibodies have been difficult to generate. In this study, production of a murine monoclonal antibody specific for a subset of human T cells was achieved by fusing a sensitized B cell (bone marrow-derived functional subpopulation of T cells defined by Ta does not correspond to any previously described human T cell subset. Furthermore, somatic cell hybridization has been shown to be a feasible method for production of monoclonal antibodies specific for subpopulations of human lymphocytes. A number of immunologic functions are attributed to T cells (thymus-derived lymphocytes), including proliferative responses to mitogens (1) and antigens (2), killing in cell-mediated lympholysis (3), and regulation of humoral and cell-mediated immunity via helper and suppressor functions (4-9). In mice, these diverse actions are mediated by specialized T-cell subsets distinguishable from one another on the basis of differences in cell surface determinants (10) (11) (12) . Humans, too, have recently been shown to have functional T-cell subsets (13-15), but subset-specific antibodies have been difficult to generate. In general, such reagents must be produced in other species, and specificity can only be achieved after extensive absorption protocols (16).
ABSTRACT
In animals and in man, diverse immunologic functions are mediated by specialized T-cell (thymus-derived lymphocyte) subsets that are distinguishable from one another on the basis of differences in cell surface determinants. Unfortunately, in humans, subset-specific antibodies have been difficult to generate. In this study, production of a murine monoclonal antibody specific for a subset of human T cells was achieved by fusing a sensitized B cell (bone marrow-derived cell) with a myeloma cell and isolating the antibody secreted by the resultant hybrid clone. This antibody binds 30-35% of peripheral T lymphocytes ( These results suggest that the functional subpopulation of T cells defined by Ta does not correspond to any previously described human T cell subset. Furthermore, somatic cell hybridization has been shown to be a feasible method for production of monoclonal antibodies specific for subpopulations of human lymphocytes. A number of immunologic functions are attributed to T cells (thymus-derived lymphocytes), including proliferative responses to mitogens (1) and antigens (2) , killing in cell-mediated lympholysis (3) , and regulation of humoral and cell-mediated immunity via helper and suppressor functions (4) (5) (6) (7) (8) (9) . In mice, these diverse actions are mediated by specialized T-cell subsets distinguishable from one another on the basis of differences in cell surface determinants (10) (11) (12) . Humans, too, have recently been shown to have functional T-cell subsets (13) (14) (15) , but subset-specific antibodies have been difficult to generate. In general, such reagents must be produced in other species, and specificity can only be achieved after extensive absorption protocols (16) .
To avoid this problem, we have utilized the technique of somatic cell hybridization (17) to produce a monoclonal antibody specific for a subset of human T cells. In a separate report (18) we describe the production of this antibody, establish that it reacted with peripheral human T cells but not B cells, and demonstrate that it precipitated its target antigen, which we have termed "Ta," from preparations of purified T cells.
In this report, we demonstrate that one-third of normal peripheral T cells are Ta+ and that Ta+ but not Ta-cells proliferate vigorously in response to concanavalin A (Con A). These and other studies described herein suggest that monoclonal anti-Ta antibody distinguishes a functional subset of human T cells. (21) . In addition, fewer than 2% of this T-cell enriched fraction were monocytes, based on staining with a-naphthyl acetate (22 (21) in RPMI 1640 medium supplemented with 25 mM Hepes buffer, 2 mM glutamine, 100 units of penicillin and 100 ,g of streptomycin per ml, and 10% pooled human serum. Stimulation with concanavalin A (Pharmacia) or phytohemagglutinin (PHA, Burroughs Wellcome) was carried out in an atmosphere of 5% C02/95% air for 4 days at 370C. T cells (100,000) were incubated in round-bottom microtiter wells in 0.2 ml with 50 ,ug of Con A or 1 pig of PHA per ml unless otherwise indicated.
METHODS AND MATERIALS
Assays were performed in triplicate and [3H]thymidine was added 18 hr before harvest (1 liCi per well; 1 Ci = 3.7 X 1010 becquerels) with a MASH II apparatus (Microbiological Associates, Walkerville, MD).
Stimulation of 100,000 T cells with tetanus toxoid (0.5 LF unit/ml) or diphtheria toxoid (0.5 LF unit/ml) (Massachusetts State Department of Public Health) was carried out in the presence of 20,000 irradiated [1500 rads (150 grays)] autologous non-T cells. In the absence of non-T cells, no proliferation was detectable. Triplicate cultures were maintained for 6 days at 370C before radiolabeling and harvesting as described.
Allogeneic mixed lymphocyte reactions (MLR) were carried out between 50,000 T responder cells and 50,000 irradiated (3000 rads) allogeneic non-T cells in a volume of 0.2 ml. Cultures were incubated in 5%i C02/95% air for 6 days at 370C, and proliferation was measured as described above. Autologous MLRs were conducted by using 100,000 T cells and 100,000 irradiated autologous non-T cells in 0.2 ml.
Unseparated T cells as well as sorted populations of Ta+ and Ta-cells were tested in these assays. When mixtures of Ta+ and Ta-cells were tested, equal numbers of each population were included in the cultures. (Fig. 2) . By contrast, the responses of Ta+ and Ta-cells to PHA were similar at higher doses of this mitogen (Fig. 3) .
RESULTS

Reactivity of Monoclonal
Responses (25), Ta+ and Ta-cells were stimulated with Con A or PHA in the presence of 20% irradiated (1500 rads) autologous non-T cells (Table 2 ). This resulted in markedly enhanced responses by Ta+ cells to both mitogens. After varying periods of incubation, the cells were washed, relabeled with anti-Ta and R/M-FITC, and analyzed in the FACS. When unsorted T cells were incubated in medium for up to 6 days (Fig. 4A) , the proportions of Ta+ and Ta-cells were unchanged. Sorted Ta+ cells retained Ta positivity, and sorted Ta-cells did not become Ta+. However, under continuous exposure to Con A, a gradual but definite loss of the Ta marker occurred (Fig. 4B) . For example, when cultures were initiated with Ta+ cells, only 20% of these cells remained Ta+ by day 6. Changes in Ta expression, such as that induced by Con A, were not detected after stimulation with PHA (Fig. 4C) , tetanus toxoid (Fig. 4D) , or allogeneic B cells (not shown). When cultures were initiated with Ta-cells, slight (5-10%) increases in the percentage of Ta+ cells were observed after stimulation with PHA, tetanus toxoid, or allogeneic cells. These changes could be accounted for by the presence of a small number of Ta+ blasts derived from cells weakly positive for Ta. Blasts with a relatively low density of Ta may appear as positive events on the FACS because of their increased surface area. (11, 26) and humans (27, 28) , and it will be of interest to test the suppressive capacity of stimulated Ta+ and Ta-populations.
Some functional comparisons can be made between the Ta+ and Ta-subsets described here and human T cell subsets reported previously. Using absorbed hetero-antisera, Schlossman and colleagues have found subsets of human T cells that are either responsive or unresponsive in the MLR (13) as well as subsets that either effect or fail to effect cell-mediated lympholysis (15 (29, 30) , the patterns do not coincide with those of Ta+ or Tj-cells. Therefore, it is unlikely that any of these previously reported subsets corresponds precisely to the populations described in this report.
In the current studies, production of an antibody specific for a subset of human T cells was achieved by fusing an antibody-secreting B cell with a myeloma cell and isQlating the resultant hybrid clone. Because antibodies secreted by such clones are highly specific and can be produced in large quantity, they should be extremely useful as discriminators of lymphocyte subpopulations. Although we have described only one monoclonal antibody, these data confirm the feasibility of the technique. Undoubtedly, additional monoclonal anti-T antibodies will soon be forthcoming, which will help to clarify the relationship between T cell surface structure and function as well as the nature of immunologic defects in human disease.
